American Oncology Network- Warrants (20/09/2028) Profit Margin

American Oncology Network- Warrants (20/09/2028) posts a profit margin of -0.44% as of December 2024. That compares with -0.73% in the prior-year period — up 40.7% year over year. That is below the sector sector average of 19.62%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, American Oncology Network- Warrants (20/09/2028)'s profit margin was -0.73%. The latest reading is -0.44% — a 40.7% year-over-year increase (period ending December 2024). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a profit margin near 19.62% is typical. American Oncology Network- Warrants (20/09/2028)'s -0.44% is lower that level. That is roughly 102.2% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

American Oncology Network- Warrants (20/09/2028)'s profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -0.44% as of December 2024; use YoY and peer views to separate noise from signal.

Context for AONCW's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 19.62%), and (3) consistency with growth and profitability. This page covers the first two; American Oncology Network- Warrants (20/09/2028)'s other metric pages and overview cover the third.